Araceli García-González

1.4k total citations
45 papers, 1.0k citations indexed

About

Araceli García-González is a scholar working on Oncology, Hematology and Surgery. According to data from OpenAlex, Araceli García-González has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Hematology and 9 papers in Surgery. Recurrent topics in Araceli García-González's work include Cancer survivorship and care (11 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Araceli García-González is often cited by papers focused on Cancer survivorship and care (11 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Araceli García-González collaborates with scholars based in United States, Mexico and Spain. Araceli García-González's co-authors include Laura González-López, Jorge Iván Gámez-Nava, Charles S. Cleeland, Tito R. Mendoza, Vanessa Cox, María E. Suarez‐Almazor, Mario Salazar-Páramo, Ernesto Germán Cardona-Muñóz, Marsha Richardson and John D. Reveille and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Araceli García-González

45 papers receiving 986 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Araceli García-González United States 15 387 233 181 159 149 45 1.0k
J. Steuart Richards United States 18 671 1.7× 76 0.3× 122 0.7× 81 0.5× 86 0.6× 38 1.1k
Nishan Sengupta United States 15 312 0.8× 73 0.3× 243 1.3× 92 0.6× 56 0.4× 42 1.1k
Kanta Kumar United Kingdom 18 713 1.8× 37 0.2× 268 1.5× 121 0.8× 46 0.3× 64 1.1k
Marieke Voshaar Netherlands 20 1.4k 3.7× 80 0.3× 634 3.5× 264 1.7× 122 0.8× 46 2.1k
Diederik De Cock Belgium 17 625 1.6× 58 0.2× 309 1.7× 147 0.9× 151 1.0× 93 1.0k
J. Michael Woolley United States 21 407 1.1× 82 0.4× 243 1.3× 32 0.2× 93 0.6× 42 1.5k
Tara Albrecht United States 12 133 0.3× 253 1.1× 394 2.2× 302 1.9× 211 1.4× 38 914
Jennifer R. Frytak United States 18 88 0.2× 164 0.7× 58 0.3× 60 0.4× 66 0.4× 31 846
Teresa Zyczynski United States 15 456 1.2× 115 0.5× 144 0.8× 107 0.7× 30 0.2× 44 1.0k
Pongthorn Narongroeknawin Thailand 16 322 0.8× 78 0.3× 91 0.5× 38 0.2× 29 0.2× 42 617

Countries citing papers authored by Araceli García-González

Since Specialization
Citations

This map shows the geographic impact of Araceli García-González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Araceli García-González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Araceli García-González more than expected).

Fields of papers citing papers by Araceli García-González

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Araceli García-González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Araceli García-González. The network helps show where Araceli García-González may publish in the future.

Co-authorship network of co-authors of Araceli García-González

This figure shows the co-authorship network connecting the top 25 collaborators of Araceli García-González. A scholar is included among the top collaborators of Araceli García-González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Araceli García-González. Araceli García-González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vilar, Eduardo, Jason Willis, Michael J. Hall, et al.. (2024). 638 Nous-209 vaccine induces shared neoantigen immunogenicity for cancer interception in healthy lynch syndrome carriers: results from phase Ib/II trial. Regular and Young Investigator Award Abstracts. A732–A732. 1 indexed citations
2.
Wang, Xin Shelley, Pedro T. Ramírez, Qiuling Shi, et al.. (2022). Patient-reported symptoms at discharge and risk of complications after gynecologic surgery. International Journal of Gynecological Cancer. 33(2). 271–277. 3 indexed citations
3.
Wang, Xin Shelley, Qiuling Shi, Loretta A. Williams, et al.. (2021). Development of a patient-reported outcome tool for assessing symptom burden during perioperative care in liver surgery: The MDASI-PeriOp-Hep. European Journal of Oncology Nursing. 52. 101959–101959. 4 indexed citations
4.
Wang, Xin Shelley, Mona Kamal, Qiuling Shi, et al.. (2021). Assessment of physical function by subjective and objective methods in patients undergoing open gynecologic surgery. Gynecologic Oncology. 161(1). 83–88. 11 indexed citations
5.
Wang, Xin Shelley, Qiuling Shi, Tito R. Mendoza, et al.. (2021). Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial. Supportive Care in Cancer. 29(10). 6099–6107. 3 indexed citations
6.
Whisenant, Meagan, Loretta A. Williams, Araceli García-González, et al.. (2020). What Do Patients With Non–Small-Cell Lung Cancer Experience? Content Domain for the MD Anderson Symptom Inventory for Lung Cancer. JCO Oncology Practice. 16(10). e1151–e1160. 13 indexed citations
7.
Kamal, Mona, Xin Shelley Wang, Qiuling Shi, et al.. (2020). A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients With Advanced Pancreatic Cancer. Journal of Pain and Symptom Management. 59(5). 1052–1058.e1. 7 indexed citations
8.
Kamal, Mona, Xin Shelley Wang, Qiuling Shi, et al.. (2020). Symptom burden and its functional impact in patients with “symptomatic” relapsed or refractory multiple myeloma. Supportive Care in Cancer. 29(1). 467–475. 19 indexed citations
9.
Wang, Xin Shelley, Qiuling Shi, Loretta A. Williams, et al.. (2019). Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN). Gynecologic Oncology. 152(3). 492–500. 12 indexed citations
10.
Williams, Loretta A., et al.. (2018). Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS). Supportive Care in Cancer. 27(3). 1021–1028. 9 indexed citations
11.
Street, Richard L., Andrea Barbo, Heather Lin, et al.. (2015). Affective Tone in Medical Encounters and Its Relationship With Treatment Adherence in a Multiethnic Cohort of Patients With Rheumatoid Arthritis. JCR Journal of Clinical Rheumatology. 21(4). 181–188. 6 indexed citations
12.
Williams, Loretta A., Araceli García-González, Jörge E. Cortes, et al.. (2015). A patient-reported outcome measure for symptoms of AML/MDS.. Journal of Clinical Oncology. 33(15_suppl). e17648–e17648. 2 indexed citations
13.
González-López, Laura, Alberto Daniel Rocha-Muñoz, Araceli García-González, et al.. (2014). Niveles de propéptido aminoterminal de procolágeno tipos i y iii y gravedad de la enfermedad pulmonar intersticial en mujeres mexicanas con esclerosis sistémica progresiva. Archivos de Bronconeumología. 51(9). 440–448. 8 indexed citations
14.
Williams, Loretta A., Araceli García-González, Patricia Ault, et al.. (2013). Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood. 122(5). 641–647. 88 indexed citations
15.
Achaval, Sofia de, Vanessa Cox, Araceli García-González, et al.. (2013). Electronic Monitoring of Oral Therapies in Ethnically Diverse and Economically Disadvantaged Patients With Rheumatoid Arthritis: Consequences of Low Adherence. Arthritis & Rheumatism. 65(6). 1421–1429. 88 indexed citations
16.
Achaval, Sofia de, et al.. (2012). Measuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring. Lupus. 21(11). 1158–1165. 66 indexed citations
17.
Williams, Loretta A., Araceli García-González, Patricia Ault, et al.. (2010). Symptom Burden In Patients with Chronic Myeloid Leukemia (CML) on Kinase Inhibitor (KI) Therapy.. Blood. 116(21). 3838–3838. 3 indexed citations
18.
Williams, Loretta A., Jörge E. Cortes, Patricia Ault, et al.. (2010). Including Patient Input In Patient-Reported Outcome Instrument Development: Examples From the MDASI-CML. Blood. 116(21). 2573–2573. 3 indexed citations
19.
González-López, Laura, Araceli García-González, Mónica Vázquez-Del Mercado, José Francisco Muñoz-Valle, & Jorge Iván Gámez-Nava. (2004). Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial.. PubMed. 31(8). 1568–74. 67 indexed citations
20.
Villalbí, Joan R., Josep Aubá, & Araceli García-González. (1995). [Evaluation of a project of primary prevention of smoking: the Barcelona PASE project].. PubMed. 66(2). 143–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026